Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro

Neuroscience

Volumn 250, Issue , 2013, Pages 614-621

  Cristofanilli, M ^a   Cymring, B ^a   Lu, A ^a   Rosenthal, H ^a   Sadiq, S A ^a  

^a Multiple Sclerosis Research Center of New York Inc   (United States)

Author keywords

Cerebrospinal fluid; In vitro model; Multiple sclerosis; Neural progenitor cells; Progressive; Repair

Indexed keywords

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EMBRYO; EMBRYONIC STEM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; OLIGODENDROGLIA; PRIORITY JOURNAL;

BDNF; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBROSPINAL FLUID; CSF; D-PBS; DULBECCO'S PHOSPHATE-BUFFERED SALINE; EAE; EDSS; EXPANDED DISABILITY STATUS SCALE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; FACS; FLUORESCENCE ACTIVATED CELL SORTING; GFAP; GLIAL FIBRILLARY ACIDIC PROTEIN; HORSERADISH PEROXIDASE; HRP; IN VITRO MODEL; MAGNETIC RESONANCE IMAGING; MBP; MRI; MS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; NEURAL PRECURSOR CELLS; NEURAL PROGENITOR CELLS; NPCS; OLIGODENDROCYTE PRECURSOR CELLS; OPCS; PPMS; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; PROGRESSIVE; Q-RT-PCR; QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION; REPAIR; SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; SPMS; SUBVENTRICULAR ZONE; SVZ;

ADULT; AGED; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CEREBROSPINAL FLUID; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURAL STEM CELLS; NEUROLOGIC EXAMINATION; NEURONS; OLIGODENDROGLIA; REAL-TIME POLYMERASE CHAIN REACTION; RNA; YOUNG ADULT;

EID: 84883029778     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.022     Document Type: Article

References (40)

1. Ahmed S., Reynolds B.A., Weiss S. BDNF enhances the differentiation but not the survival of CNS stem cell-derived neuronal precursors. J Neurosci 1995, 15:5765-5778.
2. Bonab M.M., Sahraian M.A., Aghsaie A., Karvigh S.A., Hosseinian S.M., Nikbin B., Lotfi J., Khorramnia S., Motamed M.R., Togha M., Harirchian M.H., Moghadam N.B., Alikhani K., Yadegari S., Jafarian S., Gheini M.R. Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study. Curr Stem Cell Res Ther 2012, 7:407-414.
3. Brundin L., Brismar H., Danilov A.I., Olsson T., Johansson C.B. Neural stem cells: a potential source for remyelination in neuroinflammatory disease. Brain Pathol 2003, 13:322-328.
4. Buddensiek J., Dressel A., Kowalski M., Runge U., Schroeder H., Hermann A., Kirsch M., Storch A., Sabolek M. Cerebrospinal fluid promotes survival and astroglial differentiation of adult human neural progenitor cells but inhibits proliferation and neuronal differentiation. BMC Neurosci 2010, 11:48.
5. Calza L., Giardino L., Pozza M., Bettelli C., Micera A., Aloe L. Proliferation and phenotype regulation in the subventricular zone during experimental allergic encephalomyelitis: in vivo evidence of a role for nerve growth factor. Proc Natl Acad Sci U S A 1998, 95:3209-3214.
6. Chandran S., Hunt D., Joannides A., Zhao C., Compston A., Franklin R.J. Myelin repair: the role of stem and precursor cells in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci 2008, 363:171-183.
7. Connick P., Kolappan M., Crawley C., Webber D.J., Patani R., Michell A.W., Du M.Q., Luan S.L., Altmann D.R., Thompson A.J., Compston A., Scott M.A., Miller D.H., Chandran S. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 2012, 11:150-156.
8. Cristofanilli M., Harris V.K., Zigelbaum A., Goossens A.M., Lu A., Rosenthal H., Sadiq S.A. Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice. Stem Cells Dev 2011, 20:2065-2076.
9. Doetsch F., Garcia-Verdugo J.M., Alvarez-Buylla A. Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci 1997, 17:5046-5061.
10. Fancy S.P., Kotter M.R., Harrington E.P., Huang J.K., Zhao C., Rowitch D.H., Franklin R.J. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol 2010, 225:18-23.
11. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120(Pt 3):393-399.
12. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat Rev Neurosci 2002, 3:705-714.
13. Gironi M., Bergami A., Brambilla E., Ruffini F., Furlan R., Comi G., Martino G. Immunological markers in multiple sclerosis. Neurol Sci 2000, 21:S871-S875.
14. Hafler D.A. Multiple sclerosis. J Clin Investig 2004, 113:788-794.
15. Harris V.K., Yan Q.J., Vyshkina T., Sahabi S., Liu X., Sadiq S.A. Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis. J Neurol Sci 2012, 313:167-177.
16. Hemmer B., Cepok S., Nessler S., Sommer N. Pathogenesis of multiple sclerosis: an update on immunology. Curr Opin Neurol 2002, 15:227-231.
17. Imayoshi I., Sakamoto M., Yamaguchi M., Mori K., Kageyama R. Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. J Neurosci 2010, 30:3489-3498.
18. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., Linington C., Schmidbauer M., Lassmann H. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 2000, 157:267-276.
19. Lassmann H. Mechanisms of demyelination and tissue destruction in multiple sclerosis. Clin Neurol Neurosurg 2002, 104:168-171.
20. Lassmann H., Bruck W., Lucchinetti C., Rodriguez M. Remyelination in multiple sclerosis. Mult Scler 1997, 3:133-136.
21. Lindsell C.E., Shawber C.J., Boulter J., Weinmaster G. Jagged: a mammalian ligand that activates Notch1. Cell 1995, 80:909-917.
22. Lovas G., Szilagyi N., Majtenyi K., Palkovits M., Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000, 123(Pt 2):308-317.
23. Martino G., Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006, 7:395-406.
24. Mashayekhi F., Salehi Z., Jamalzadeh H.R. Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis. Acta Medica (Hradec Kralove) 2012, 55:83-86.
25. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127.
26. Miller D.H., Leary S.M. Primary-progressive multiple sclerosis. Lancet Neurol 2007, 6:903-912.
27. Ming G.L., Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 2005, 28:223-250.
28. Nait-Oumesmar B., Picard-Riera N., Kerninon C., Decker L., Seilhean D., Hoglinger G.U., Hirsch E.C., Reynolds R., Baron-Van Evercooren A. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A 2007, 104:4694-4699.
29. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N Engl J Med 2000, 343:938-952.
30. Nyfeler Y., Kirch R.D., Mantei N., Leone D.P., Radtke F., Suter U., Taylor V. Jagged1 signals in the postnatal subventricular zone are required for neural stem cell self-renewal. EMBO J 2005, 24:3504-3515.
31. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., Sorensen P.S., Bruck W., Lucchinetti C., Lassmann H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129:3165-3172.
32. Picard-Riera N., Decker L., Delarasse C., Goude K., Nait-Oumesmar B., Liblau R., Pham-Dinh D., Evercooren A.B. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A 2002, 99:13211-13216.
33. Pluchino S., Martino G. The therapeutic plasticity of neural stem/precursor cells in multiple sclerosis. J Neurol Sci 2008, 265:105-110.
34. Pluchino S., Muzio L., Imitola J., Deleidi M., Alfaro-Cervello C., Salani G., Porcheri C., Brambilla E., Cavasinni F., Bergamaschi A., Garcia-Verdugo J.M., Comi G., Khoury S.J., Martino G. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 2008, 131:2564-2578.
35. Pluchino S., Zanotti L., Brini E., Ferrari S., Martino G. Regeneration and repair in multiple sclerosis: the role of cell transplantation. Neurosci Lett 2009, 456:101-106.
36. Sadiq S (2005) Multiple sclerosis. In: Merritt's textbook of neurology, 11th ed., vol. 134 (Rowland LP, ed.), Lippincott Williams & Wilkins (LMW), Philadelphia, PA, USA. 941-962.
37. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278-285.
38. Yagita Y., Kitagawa K., Ohtsuki T., Takasawa K., Miyata T., Okano H., Hori M., Matsumoto M. Neurogenesis by progenitor cells in the ischemic adult rat hippocampus. Stroke 2001, 32:1890-1896.
39. Zhang R., Zhang Z., Zhang C., Zhang L., Robin A., Wang Y., Lu M., Chopp M. Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat. J Neurosci 2004, 24:5810-5815.
40. Zhang R.L., Zhang Z.G., Chopp M. Neurogenesis in the adult ischemic brain: generation, migration, survival, and restorative therapy. Neuroscientist 2005, 11:408-416.